Correlation Between TRADELINK ELECTRON and CRISPR Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TRADELINK ELECTRON and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TRADELINK ELECTRON and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TRADELINK ELECTRON and CRISPR Therapeutics AG, you can compare the effects of market volatilities on TRADELINK ELECTRON and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TRADELINK ELECTRON with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of TRADELINK ELECTRON and CRISPR Therapeutics.

Diversification Opportunities for TRADELINK ELECTRON and CRISPR Therapeutics

1.0
  Correlation Coefficient

No risk reduction

The 3 months correlation between TRADELINK and CRISPR is 1.0. Overlapping area represents the amount of risk that can be diversified away by holding TRADELINK ELECTRON and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and TRADELINK ELECTRON is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TRADELINK ELECTRON are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of TRADELINK ELECTRON i.e., TRADELINK ELECTRON and CRISPR Therapeutics go up and down completely randomly.

Pair Corralation between TRADELINK ELECTRON and CRISPR Therapeutics

If you would invest  4,080  in CRISPR Therapeutics AG on November 6, 2024 and sell it today you would earn a total of  0.00  from holding CRISPR Therapeutics AG or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

TRADELINK ELECTRON  vs.  CRISPR Therapeutics AG

 Performance 
       Timeline  
TRADELINK ELECTRON 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TRADELINK ELECTRON has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, TRADELINK ELECTRON is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
CRISPR Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CRISPR Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, CRISPR Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

TRADELINK ELECTRON and CRISPR Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TRADELINK ELECTRON and CRISPR Therapeutics

The main advantage of trading using opposite TRADELINK ELECTRON and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TRADELINK ELECTRON position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.
The idea behind TRADELINK ELECTRON and CRISPR Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Content Syndication
Quickly integrate customizable finance content to your own investment portal